Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 2005年10月20日，鸿洋神海洋生物与台湾居民梁永文先生签署《合资经营荣成百合生物技术有限公司合同》，约定成立中外合资企业荣成百合，投资总额为100万美元，其中鸿洋神海洋生物占75%，梁永文占25%。2005年11月14日，威海市经济贸易委员会出具威经贸投外资核[2005]001号《外商投资技术改造项目核准通知书》，核准鸿洋神海洋生物与梁永文合资经营荣成百合。2005年11月16日，荣成百合取得了荣成市工商行政管理局核发的注册号为企合鲁威总副字第004843号的《企业法人营业执照》。2013年7月16日，公司股东会决议荣成百合整体变更为股份公司。2013年10月9日，原公司股东作为拟变更设立的股份公司发起人签署了《威海百合生物技术股份有限公司发起人协议》。同日，各发起人召开股份公司创立大会暨首次股东大会，审议通过《关于威海百合生物技术股份有限公司筹办情况的报告》、《威海百合生物技术股份有限公司章程》等议案，并选举产生股份公司第一届董事会成员和监事会成员。2013年11月14日，公司在威海市工商行政管理局办理了工商变更登记，并领取注册号为371082400003716的《企业法人营业执照》，注册资本为4,500万元。 公司是一家专业从事营养保健食品的研发、生产和销售的国家高新技术企业。历经多年的研发与积累，公司已形成软胶囊、硬胶囊、片剂、粉剂、口服液、滴剂、瓶装饮品及袋装饮品等多剂型、规模化的生产能力，同时建立了高效的研发管理及供应链管理体系，能为国内外客户提供涵盖产品定位、配方研究、生产审批及成品生产等全流程服务。 公司同时坚持自主品牌战略，在为国内外营养保健食品品牌运营商提供合同生产服务的同时，还积极发展自主品牌。公司目前拥有“百合康”、“福仔”、“鸿洋神”及“足力行”等自主品牌，分别针对家庭、婴幼儿、高端人士、中老年人等不同类型的消费群体，其中“”品牌系经国家工商行政管理总局认定的中国驰名商标。公司未来还将加强婴幼儿辅助食品、运动营养食品、特殊医学用途配方食品等系列产品的开发力度，形成品类齐全、满足不同消费者需求的产品结构。
Main Business 专业从事营养保健食品的研发、生产和销售
Legal Representative 刘新力
Top Executives
董事长：刘新力
董事：刘海涛,姚建伟,刘旭东,王丽娜,王文通
独立董事：李秉胜,钟志刚,刘学伟
Top 5 Shareholder
Shareholder name Nature Holding Date
刘新力限售股40.94%30/09/2024
刘兆民限售股3.03%30/09/2024
刘禄增流通A股2.67%30/09/2024
王文通流通A股2.65%30/09/2024
刘新志流通A股2.16%30/09/2024
Company Secretary 孙同波
Solicitors 北京市君泽君律师事务所
Auditors 容诚会计师事务所（特殊普通合伙）
Tel No 0631-7833031
Fax No 0631-7830130
Website www.baiheshengwu.com
Email suntongbo@sohu.com
Company Address
Register: 山东省荣成市天鹅湖经济技术开发区成大路552号
Office: 山东省荣成市天鹅湖经济技术开发区成大路2899号
Listing Date 25/01/2022
Shares Capital
Shares Capital: 64,000,000
Total A Share: 64,000,000
Listed A Share: 35,789,350
Non-tradable A Share: 28,210,650
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 2.640
DPS(RMB)* ¥ 0.750
NBV Per Share(RMB)* ¥ 23.664
Market Capitalization(RMB) 1.329B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.